SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-22-000918
Filing Date
2022-05-06
Accepted
2022-05-06 06:00:47
Documents
1
Period of Report
2022-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5226
  Complete submission text file 0001640334-22-000918.txt   6821
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Issuer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 10 EAST LEE STREET SUITE 2705 BALTIMORE MD 21202
Business Address
Robinson James George (Reporting) CIK: 0001651844 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12033 | Film No.: 22898681